Mosaic Immunoengineering Stock Analysis

CPMV Stock  USD 1.00  0.01  1.01%   
Mosaic Immunoengineering is overvalued with Real Value of 0.76 and Hype Value of 1.0. The main objective of Mosaic Immunoengineerin otc analysis is to determine its intrinsic value, which is an estimate of what Mosaic Immunoengineering is worth, separate from its market price. There are two main types of Mosaic Immunoengineerin's stock analysis: fundamental analysis and technical analysis.
The Mosaic Immunoengineerin otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Mosaic Immunoengineering. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.

Mosaic OTC Stock Analysis Notes

About 89.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.51. Mosaic Immunoengineering last dividend was issued on the 2nd of March 2007. The entity had 1:500 split on the 2nd of December 2020. Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. Mosaic Immunoengineerin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for Mosaic Immunoengineering is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Mosaic Immunoengineering please contact the company at 657-208-0890 or go to https://www.mosaicie.com.

Mosaic Immunoengineering Investment Alerts

Mosaic Immunoengineerin is way too risky over 90 days horizon
Mosaic Immunoengineerin has some characteristics of a very speculative penny stock
Mosaic Immunoengineerin appears to be risky and price may revert if volatility continues
Mosaic Immunoengineerin has a very high chance of going through financial distress in the upcoming years
Mosaic Immunoengineering currently holds 735.15 K in liabilities. Mosaic Immunoengineering has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mosaic Immunoengineerin until it has trouble settling it off, either with new capital or with free cash flow. So, Mosaic Immunoengineerin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mosaic Immunoengineering sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mosaic to invest in growth at high rates of return. When we think about Mosaic Immunoengineerin's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (3.68 M) with profit before overhead, payroll, taxes, and interest of 0.
Mosaic Immunoengineering currently holds about 205.99 K in cash with (679.24 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Roughly 89.0% of the company shares are held by company insiders

Mosaic Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mosaic Immunoengineerin's market, we take the total number of its shares issued and multiply it by Mosaic Immunoengineerin's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 2nd of December, Mosaic Immunoengineerin secures the Mean Deviation of 6.67, downside deviation of 18.32, and Risk Adjusted Performance of 0.0571. Mosaic Immunoengineering technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have collected data for nineteen technical drivers for Mosaic Immunoengineerin, which can be compared to its peers in the industry. Please verify Mosaic Immunoengineering variance and potential upside to decide if Mosaic Immunoengineering is priced some-what accurately, providing market reflects its recent price of 1.0 per share. Given that Mosaic Immunoengineering is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.

Mosaic Immunoengineering Price Movement Analysis

Execute Study
The output start index for this execution was twenty-seven with a total number of output elements of thirty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mosaic Immunoengineerin middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mosaic Immunoengineering. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Mosaic Immunoengineerin Outstanding Bonds

Mosaic Immunoengineerin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mosaic Immunoengineering uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mosaic bonds can be classified according to their maturity, which is the date when Mosaic Immunoengineering has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Mosaic Immunoengineerin Predictive Daily Indicators

Mosaic Immunoengineerin intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mosaic Immunoengineerin otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mosaic Immunoengineerin Forecast Models

Mosaic Immunoengineerin's time-series forecasting models are one of many Mosaic Immunoengineerin's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mosaic Immunoengineerin's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Mosaic OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Mosaic Immunoengineerin prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mosaic shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Mosaic Immunoengineerin. By using and applying Mosaic OTC Stock analysis, traders can create a robust methodology for identifying Mosaic entry and exit points for their positions.
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. Mosaic Immunoengineerin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Mosaic Immunoengineerin to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module

Additional Tools for Mosaic OTC Stock Analysis

When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.